Free Trial
NYSE:RFL

Rafael Q3 2025 Earnings Results & Report

Rafael logo
$1.46 +0.03 (+1.96%)
Closing price 03:59 PM Eastern
Extended Trading
$1.46 +0.00 (+0.14%)
As of 07:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Rafael reported Q3 2025 earnings on June 11, 2025. The company reported EPS of -$0.19, while revenue was $0.36 million.

Earnings Announcement Details

Quarter
Q3 2025
Report Date
Time
Before Market Opens
Conference Call
7:00 AM ET

Rafael EPS Results

Actual EPS
-$0.19
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Rafael Revenue Results

Actual Revenue
$0.36 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Rafael's Q4 2026 earnings is estimated for Wednesday, October 28, 2026, based on past reporting schedules, with a conference call scheduled on Tuesday, October 27, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Rafael Q3 2025 Earnings FAQ

Rafael (NYSE:RFL) reported earnings of -$0.19 per share for Q3 2025. The report was announced on Wednesday, June 11, 2025.

Rafael reported revenue of $0.36 million for Q3 2025.

Rafael's next earnings date is estimated for Wednesday, October 28, 2026. MarketBeat tracks confirmed and estimated earnings dates for Rafael on the company's earnings history page.

Rafael Earnings Headlines

Contrasting Rafael (NYSE:RFL) and Innoviva (NASDAQ:INVA)
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.tc pixel
Reviewing Rafael (NYSE:RFL) & vTv Therapeutics (NASDAQ:VTVT)
See More Rafael Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Rafael? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Rafael and other key companies, straight to your email.

About Rafael

Rafael (NYSE:RFL) is a diversified holding company focused primarily on life sciences and real estate. Through its life sciences activities, the company has supported the development of therapies designed to address serious diseases, including cancer, with a particular emphasis on treatments that target cancer-cell metabolism.

The company’s real estate interests include commercial properties and related investments. Rafael Holdings has historically maintained a connection to Rafael Pharmaceuticals, a biotechnology company involved in oncology drug development, although its operating structure and investments may change over time.

Rafael Holdings was established as a spin-off from IDT Corporation. The company is based in the United States and serves its markets through its investment holdings rather than through a broad consumer-facing product portfolio.

View Rafael Profile